| scholarly article | Q13442814 |
| P50 | author | Xiaoyuan Chen | Q67123714 |
| P2093 | author name string | Sanjiv S Gambhir | |
| Weibo Cai | |||
| Yun Wu | |||
| Xianzhong Zhang | |||
| Zhengming Xiong | |||
| Jeffery R Tseng | |||
| P2860 | cites work | Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand | Q24292425 |
| Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD | Q24805375 | ||
| Integrins: bidirectional, allosteric signaling machines | Q27860700 | ||
| Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins | Q30310466 | ||
| Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. | Q30310994 | ||
| Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells | Q30493883 | ||
| Graphical analysis of PET data applied to reversible and irreversible tracers | Q30620159 | ||
| New insight into the analysis of 6-[18F]fluoro-L-DOPA PET dynamic data in brain tissue without an irreversible compartment: comparative study of the Patlak and Logan analyses. | Q30802221 | ||
| Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies | Q31059628 | ||
| Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. | Q32053981 | ||
| VEGF-integrin interplay controls tumor growth and vascularization. | Q33821325 | ||
| Integrin alpha v beta 3-targeted imaging of lung cancer | Q34768362 | ||
| Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis | Q35056623 | ||
| A review of graphical methods for tracer studies and strategies to reduce bias | Q35617870 | ||
| Integrins: regulators of tissue function and cancer progression. | Q36074575 | ||
| Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts | Q40440587 | ||
| Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. | Q40457486 | ||
| In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts | Q40497208 | ||
| 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis | Q40580104 | ||
| Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography | Q43561095 | ||
| Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. | Q44203808 | ||
| Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting | Q44284738 | ||
| MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide | Q44735123 | ||
| [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates | Q44735126 | ||
| Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation | Q44740884 | ||
| MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide | Q44876771 | ||
| Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide | Q45008593 | ||
| MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides | Q45068701 | ||
| microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide | Q46115376 | ||
| Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging | Q46789795 | ||
| Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins | Q61764268 | ||
| Sodium dodecyl sulfate-stable complexes of echistatin and RGD-dependent integrins: a novel approach to study integrins | Q73097990 | ||
| Alphav integrins mediate adhesion and migration of breast carcinoma cell lines | Q74313522 | ||
| Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting | Q78143346 | ||
| Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability | Q80522056 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 113-121 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. | |
| P478 | volume | 47 |
| Q33956262 | (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer |
| Q39861931 | (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging |
| Q39892388 | (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging |
| Q40023168 | (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression |
| Q90183457 | 18F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography |
| Q30497615 | 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression |
| Q34205400 | 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression. |
| Q33925952 | 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics |
| Q39844585 | 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics |
| Q33689501 | A One-Pot Three-Component Double-Click Method for Synthesis of [67Cu]-Labeled Biomolecular Radiotherapeutics |
| Q34419762 | A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects |
| Q41907825 | A high-sensitivity small animal SPECT system |
| Q35009658 | A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging |
| Q35227801 | A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression |
| Q49587716 | Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging |
| Q39269129 | Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors. |
| Q36514879 | Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? |
| Q33581665 | An engineered knottin peptide labeled with 18F for PET imaging of integrin expression |
| Q35082412 | Applications of Molecular Imaging |
| Q34632573 | Are quantum dots ready for in vivo imaging in human subjects? |
| Q48356620 | Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells |
| Q35047646 | Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosis |
| Q48134659 | Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurements |
| Q34282895 | Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression |
| Q26771417 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 |
| Q30820507 | Combination of an Integrin-Targeting NIR Tracer and an Ultrasensitive Spectroscopic Device for Intraoperative Detection of Head and Neck Tumor Margins and Metastatic Lymph Nodes |
| Q37288360 | Comparison of the accuracy of 99mTc-3P4-RGD2 SPECT and CT in diagnosing solitary pulmonary nodules |
| Q39104091 | Comparison of three dimeric 18F-AlF-NOTA-RGD tracers |
| Q35629161 | Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice |
| Q53205623 | Differential diagnosis of solitary pulmonary nodules using ⁹⁹mTc-3P₄-RGD₂ scintigraphy. |
| Q57621665 | Dimeric [68Ga]DOTA-RGD Peptide Targeting αvβ3 Integrin Reveals Extracellular Matrix Alterations after Myocardial Infarction |
| Q30524330 | Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe |
| Q35024556 | Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell |
| Q33447473 | Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity |
| Q33387746 | Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities |
| Q33708506 | Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects |
| Q34662001 | Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging |
| Q33867187 | Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent |
| Q35167459 | Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability |
| Q36113183 | Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. |
| Q35760732 | Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents |
| Q35379070 | F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging |
| Q34556242 | FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues |
| Q33833584 | Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein |
| Q33812205 | High-affinity peptide against MT1-MMP for in vivo tumor imaging |
| Q36234070 | Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a (64)Cu-labeled streptavidin/biotin-based dimeric RGD peptide. |
| Q34977050 | Imaging and cancer: a review |
| Q33786497 | Imaging of VEGF receptor in a rat myocardial infarction model using PET |
| Q41945829 | Imaging the glycosylation state of cell surface glycoproteins by two-photon fluorescence lifetime imaging microscopy. |
| Q34473434 | Immuno-PET imaging of tumor endothelial marker 8 (TEM8) |
| Q39804673 | Imparting multivalency to a bifunctional chelator: a scaffold design for targeted PET imaging probes |
| Q33993075 | Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future |
| Q37060623 | Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers |
| Q37178786 | Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers |
| Q37081396 | Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers |
| Q37540738 | Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by (18)F-labeled Arg-Gly-Asp positron-emission tomography |
| Q37236103 | Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics |
| Q36865548 | Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer |
| Q51751868 | Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factor. |
| Q35109294 | MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides |
| Q36804990 | Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits |
| Q37600765 | Molecular imaging in clinical trials |
| Q36129937 | Molecular imaging of prostate cancer: PET radiotracers |
| Q37207397 | Molecular imaging of prostate cancer: a concise synopsis |
| Q30481645 | Molecular imaging of vessels in mouse models of disease |
| Q60923329 | Multimodal and Multiscale Analysis Reveals Distinct Vascular, Metabolic and Inflammatory Components of the Tissue Response to Limb Ischemia |
| Q38369824 | Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency |
| Q36625118 | N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression |
| Q37003713 | Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q30528528 | Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos). |
| Q33358260 | Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes |
| Q39868638 | Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib |
| Q46083932 | Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers |
| Q28817842 | Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene |
| Q36777406 | Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers |
| Q39633289 | Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels. |
| Q37366243 | PET Imaging of Angiogenesis |
| Q42726009 | PET Imaging of Integrin αVβ3 Expression |
| Q37374442 | PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development |
| Q35869269 | PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. |
| Q34062271 | PET of malignant melanoma using 18F-labeled metallopeptides |
| Q36746620 | Peptide heterodimers for molecular imaging |
| Q33846924 | Peptides and peptide hormones for molecular imaging and disease diagnosis |
| Q34697688 | Positron emission tomography imaging of cancer biology: current status and future prospects |
| Q24596241 | Positron emission tomography imaging of prostate cancer |
| Q33991881 | Positron emission tomography molecular imaging for drug development |
| Q36777285 | Positron emission tomography tracers for imaging angiogenesis |
| Q37100705 | Practical method for radioactivity distribution analysis in small-animal PET cancer studies |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q59465727 | Preclinical validations of [F]FPyPEGCBT-(RGDfK): a F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis |
| Q61817693 | Preparation and Evaluation of ZD2 Peptide Cu-DOTA Conjugate as a Positron Emission Tomography Probe for Detection and Characterization of Prostate Cancer |
| Q39941113 | Quantitative PET imaging of VEGF receptor expression |
| Q40177482 | Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody |
| Q28729872 | Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model |
| Q36107186 | Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model |
| Q34330885 | Quantitative cardiovascular magnetic resonance for molecular imaging |
| Q27023605 | Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging |
| Q38161395 | RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis. |
| Q26801806 | Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q39047828 | Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression |
| Q37480688 | Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency |
| Q28072021 | Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging |
| Q37990409 | Radiolabelled RGD peptides for imaging and therapy |
| Q37207310 | Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. |
| Q37990399 | Radiopharmaceutical development of radiolabelled peptides |
| Q51385423 | Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts. |
| Q34134418 | Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog |
| Q41709750 | Solid-phase synthesis and fluorine-18 radiolabeling of cycloRGDyK. |
| Q37995451 | Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments. |
| Q39734703 | Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes |
| Q39063433 | Synthesis and biological evaluation of RGD-conjugated MEK1/2 kinase inhibitors for integrin-targeted cancer therapy |
| Q38962269 | Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours. |
| Q34380877 | Tetraspecific ligand for tumor-targeted delivery of nanomaterials |
| Q88502315 | Theranostics and metabolotheranostics for precision medicine in oncology |
| Q41950691 | Toward redesigning the PEG surface of nanocarriers for tumor targeting: impact of inner functionalities on size, charge, multivalent binding, and biodistribution |
| Q39444594 | Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging. |
| Q54643298 | Turning the tide in lung cancer |
| Q35563176 | Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble. |
| Q35785243 | Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma |
| Q45287510 | [¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrins. |
| Q34282774 | microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) |
Search more.